These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20073278)

  • 1. South African guidelines on venous thromboembolism.
    Webb MJ; Mlombe Y; Louw VJ
    S Afr Med J; 2009 Sep; 99(9):614; author reply 614. PubMed ID: 20073278
    [No Abstract]   [Full Text] [Related]  

  • 2. American College of Chest Physicians evidence-based guidelines for venous thromboembolic prophylaxis: the guideline wars are over.
    Lieberman JR
    J Am Acad Orthop Surg; 2012 Jun; 20(6):333-5. PubMed ID: 22661562
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of initiating rivaroxaban versus low-molecular weight heparin plus warfarin in patients admitted to the hospital for venous thromboembolism.
    Hom L; Sobieraj DM
    Int J Cardiol; 2015 Nov; 198():87-8. PubMed ID: 26159242
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of venous thromboembolism after acute spinal cord injury with low-dose heparin or low-molecular-weight heparin.
    Paciaroni M; Ageno W; Agnelli G
    Thromb Haemost; 2008 May; 99(5):978-80. PubMed ID: 18449438
    [No Abstract]   [Full Text] [Related]  

  • 5. [Guidelines for prevention of venous thromboembolism in Austria].
    Thaler H
    Wien Klin Wochenschr; 2008; 120(11-12):383-4. PubMed ID: 18709527
    [No Abstract]   [Full Text] [Related]  

  • 6. [Secondary prevention of venous thromboembolism in patients with cancer].
    Meyer G
    Rev Prat; 2011 Nov; 61(9):1249-51. PubMed ID: 22308809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes.
    Duhl AJ; Paidas MJ; Ural SH; Branch W; Casele H; Cox-Gill J; Hamersley SL; Hyers TM; Katz V; Kuhlmann R; Nutescu EA; Thorp JA; Zehnder JL;
    Am J Obstet Gynecol; 2007 Nov; 197(5):457.e1-21. PubMed ID: 17980177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overuse of Bridging Anticoagulation for Patients With Venous Thromboembolism: First, Do No Harm.
    Brotman DJ; Streiff MB
    JAMA Intern Med; 2015 Jul; 175(7):1169-70. PubMed ID: 26011244
    [No Abstract]   [Full Text] [Related]  

  • 9. Perioperative anticoagulant management.
    Grant PJ; Brotman DJ; Jaffer AK
    Med Clin North Am; 2009 Sep; 93(5):1105-21. PubMed ID: 19665623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs.
    Caprini JA; Tapson VF; Hyers TM; Waldo AL; Wittkowsky AK; Friedman R; Colgan KJ; Shillington AC;
    J Vasc Surg; 2005 Oct; 42(4):726-33. PubMed ID: 16242561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulants for thrombosis prophylaxis following surgery: a continuing saga.
    Caprini JA
    Thromb Haemost; 2008 Jun; 99(6):993-4. PubMed ID: 18521498
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-molecular-weight heparin for thromboprophylaxis.
    Camporese G; Bernardi E
    Curr Opin Pulm Med; 2009 Sep; 15(5):443-54. PubMed ID: 19593139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent venous thromboembolism while on anticoagulant therapy.
    Thachil J
    Blood Rev; 2012 Jul; 26(4):175-81. PubMed ID: 22560652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Focus on the prevention, treatment and management of venous thromboembolism: what can we learn from the 9th ACCP guidelines].
    Wang C; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(24):1857-9. PubMed ID: 24124733
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: a double-blind, dose-ranging study. Ardeparin Arthroplasty Study Group.
    Heit JA; Berkowitz SD; Bona R; Cabanas V; Corson JD; Elliott CG; Lyons R
    Thromb Haemost; 1997 Jan; 77(1):32-8. PubMed ID: 9031445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversial issues in thromboprophylaxis with low-molecular weight heparins in palliative care.
    Tassinari D; Santelmo C; Scarpi E; Tombesi P; Sartori S
    J Pain Symptom Manage; 2008 Aug; 36(2):e3-4. PubMed ID: 18655952
    [No Abstract]   [Full Text] [Related]  

  • 17. The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence.
    Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
    Arch Intern Med; 1997 Nov; 157(20):2317-21. PubMed ID: 9361572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New oral anticoagulants in venous thromboembolism prophylaxis in orthopaedic patients: are they really better?
    Huo MH
    Thromb Haemost; 2011 Jul; 106(1):45-57. PubMed ID: 21544312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthopedic pearls in deep vein thrombosis: questions frequently asked.
    Muntz JE
    J Surg Orthop Adv; 2003; 12(4):225-7. PubMed ID: 15008287
    [No Abstract]   [Full Text] [Related]  

  • 20. Low daily aspirin doses reduce risk of blood clots as effectively as higher doses.
    Rollins G
    Rep Med Guidel Outcomes Res; 2001 Feb; 12(4):5-7. PubMed ID: 11767795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.